the obesity-related cancers are heavily concentrated among organs involved in digestion and metabolism, like the liver and pancreas, for example, as well as among gynecologic cancers, including breast and uterus
In addition to being approved to treat T2DM, GLP-1 RAs prevented the development of new-onset T2DM in overweight/obese participants as exemplified by semaglutide in the SELECT CVOT (NCT03574597) [HR for HbA1c 6.5%: 0.27 (95% CI 0.240.31)] [48]
doi: 10.1007/s00223-015-9993-5 10 DriessenJHvan OnzenoortHAStarup-LindeJHenryRBurdenAMNeefCet al
PubMed evidence trail For Noom Med vs Calibrate: GLP-1 + Coaching Programs Compared, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available
Le Dr DAlessio croit que la science entourant les agonistes du GLP-1 nen est qu' ses dbuts
Other supplements may promote weight management by addressing different aspects of overall metabolic health